Atlas Trials

A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects

Clinical trial NCT04527484 · UNKNOWN

Trial details

NCT number
NCT04527484
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2020-08-20
Primary completion
2021-01-10
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.